STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3036 by analyst upside · 2026-06-27
SRRK
Scholar Rock Holding Corporation
Healthcare · Market Cap $7B · P/E 0x
ANALYST PRICE TARGET
+8.3%
implied upside to consensus target
Current Price $54.76
Consensus Target $59.31
Bull Target $70.0
Bear Target $48.0
Analysts Covering 16
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
13
Hold
0
Sell
0
52-Week Low $27.07
52-Week High $55.18
YTD Return +27.9%
FUNDAMENTALS
Market Cap $7B
P/E Ratio (TTM) N/A
Forward P/E -23.1x
EPS (TTM) $-3.45
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $27.07
52-Week High $55.18
Current Price $54.76
Bear Target $48.0
Bull Target $70.0
● Now $54.76 ● Target $59.31
TRADING DATA
Avg Volume 1.5M
YTD Return +27.9%
Analyst Count 16
Consensus Buy
Upside to Target +8.3%
Last Updated 2026-06-27

ANALYST SUMMARY

Scholar Rock Holding Corporation (SRRK) is currently trading at $54.76 with a Wall Street consensus price target of $59.31, implying potential upside of 8.3% over the next 12 months. 16 analysts currently cover SRRK, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $70.0, while the most cautious has a target of $48.0.

SRRK operates in the Healthcare sector with a market capitalisation of $7B. The stock is up 27.9% year-to-date and is currently trading near the upper end of its 52-week range of $27.07 – $55.18.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SRRK, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays — Reiterated
Overweight → Overweight 2026-05-08 Building track record
HC Wainwright & Co. — Reiterated
Buy → Buy 2026-05-08 31% win rate (48 calls)
Canaccord Genuity ● Initiated
Buy 2026-04-21 Building track record
Wedbush — Reiterated
Outperform → Outperform 2026-04-01 Building track record
JP Morgan — Reiterated
Overweight → Overweight 2026-03-16 43% win rate (7 calls)
Citigroup — Reiterated
Buy → Buy 2026-03-04 Building track record
BMO Capital — Reiterated
Outperform → Outperform 2026-03-04 Building track record
Truist Securities — Reiterated
Buy → Buy 2026-03-04 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
71
out of 100
Coverage depth
22/30
Consensus clarity
22/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →